Cornerstone Investment Partners, LLC
Source: SEC Form 13F · as of Mar 2026Cornerstone Investment Partners, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $330.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$330.6M
| Company | Shares | Value |
|---|---|---|
| CORCencora Inc. | 271,971 | $85.4M |
| MCKMcKesson Corporation | 93,529 | $80.9M |
| IQVIQVIA Holdings Inc. | 433,478 | $73.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 165,011 | $44.7M |
| ELVElevance Health Inc. | 142,647 | $41.8M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3,594 | $620K |
| LGNDLigand Pharmaceuticals Incorporated | 2,205 | $440K |
| PAHCPHIBRO ANIMAL HEALTH CORP | 6,616 | $366K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 30,687 | $298K |
| EBSEmergent BioSolutions Inc. | 33,620 | $279K |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 5,168 | $267K |
| OSCROscar Health Inc. | 22,165 | $254K |
| MOHMolina Healthcare Inc | 1,846 | $246K |
| INVAInnoviva, Inc. | 10,434 | $243K |
| ALHCAlignment Healthcare Inc. | 13,492 | $238K |
| PBIPROVENTION BIO, INC. | 20,623 | $228K |
| AUPHAurinia Pharmaceuticals Inc. | 14,497 | $215K |
| ACADACADIA PHARMACEUTICALS INC | 9,538 | $212K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.